pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Democrats’ Midterm Win Promises Medicaid Reversal and ACA Subsidy Restoration for Hospitals

Nov 6, 2026·read at STAT ↗RegulatoryPositive

The November midterm election gave Democrats control of both the House and Senate, a result analysts describe as a landslide. The shift is expected to create a more favorable environment for hospitals that have faced pressure from Republican-led efforts to cut Medicaid payments.

Within the first weeks of the new Congress, Democratic leaders plan to roll back the Medicaid reductions that were enacted under the previous administration’s tax law. They also intend to permanently restore the enhanced subsidies for Affordable Care Act plans that expired earlier this year, measures that would expand insurance coverage and increase reimbursements for hospitals.

In addition, Democrats aim to block a niche drug discount program that hospitals have criticized as harmful to their revenue. By preventing the implementation of that model, the party hopes to protect hospital margins while pursuing broader coverage expansions.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Democrats’ midterm landslide spells relief for hospitals”

read at STAT ↗
513 words · retrieved 22m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN
drugs
evolocumab
topics
CardiologyGene Therapy (AAV)

related stories

  • 2h agoSTAT+: New tumor cases show common gene therapy tool can come with riskSTAT
  • 3h agoSTAT+: Amgen’s Repatha linked to fewer heart attacksSTAT
  • Jul 24Scribe records upsized $129M IPO to bankroll lipid-lowering genetic medsFierce Biotech
  • 2h agoSatellos' new Duchenne study endpoint; Amgen's Repatha cuts heart attack riskEndpoints
  • 3h agoVoyager, C4 cut workforcesBioSpace